Establishment of a Quantitative Medicine Innovation Network: Scope, Feasibility, and Opportunities; Request for Information
The Center for Drug Evaluation and Research (CDER) within the Food and Drug Administration (FDA or A...
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Federal Register
- Region
- USA
- Scope
- Regulatory
- Published
- August 5, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
The Center for Drug Evaluation and Research (CDER) within the Food and Drug Administration (FDA or A...
Source route
Continue on federalregister.gov
Leave the platform to read the original full article on the publisher site.
Source: Federal Register
Scope: Regulatory
Related coverage
More related coverage
Medicine supply management
An overview of the systems and processes DHSC and NHS England use for responding to medicine shortag...
Ensuring the efficient supply and distribution of medicines to patients
Guidance on the roles and responsibilities of marketing authorisation holders, wholesalers and procu...
Digital Inclusion Action Plan: One Year On
Progress report on delivering the Digital Inclusion Action Plan.
FilmArray® NGDS Warrior Panel
Testing has identified a potential reduction in sensitivity to the 2026 Bundibugyo outbreak strain w...